1. Home
  2. BATRA vs RCUS Comparison

BATRA vs RCUS Comparison

Compare BATRA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$55.04

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$28.42

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRA
RCUS
Founded
1991
2015
Country
United States
United States
Employees
1610
601
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BATRA
RCUS
Price
$55.04
$28.42
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$60.00
$31.90
AVG Volume (30 Days)
50.7K
1.3M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$12.40
N/A
Revenue Next Year
$8.54
$45.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.50
$8.84
52 Week High
$58.37
$31.74

Technical Indicators

Market Signals
Indicator
BATRA
RCUS
Relative Strength Index (RSI) 45.05 51.38
Support Level $52.23 $20.20
Resistance Level $55.97 $28.72
Average True Range (ATR) 1.15 1.33
MACD -0.35 -0.16
Stochastic Oscillator 14.94 50.83

Price Performance

Historical Comparison
BATRA
RCUS

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: